Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Patients with diabetes and hypertension may be affected differently in COVID-19 infections.
Read More »Best Practices for Treating Comorbidities in Patients with COVID-19
Air Pollution Alters Gut Microbiome and Increases Risk For Diabetes
Exposure to air pollutants alters the composition of gut microbiota, subsequently increases the risk of obesity, diabetes, gastrointestinal disorders, and other chronic illnesses.
Read More »Comparisons of GLP-1 Agonists
Which GLP-1RA provides better benefits?
Read More »Empagliflozin Produces Liver Fat Reduction in Randomized Control Trial
Could empagliflozin contribute to the early treatment of NAFLD in patients with T2DM?
Read More »The Effects of Type 2 Patients Refusing Insulin
There is a strong need to understand the relationship between the refusal of insulin therapy in patients with type 2 diabetes and worsening blood glucose levels.
Read More »Can ACE Inhibitors Lower Type 2 Diabetes Risk?
ACE inhibitors may have potential uses in diabetes, aside from lowering blood pressure.
Read More »Many People with Type 2 Diabetes Need Better Sleep
Sleep Disorders, HbA1c, and their connection with type 2 diabetes patients.
Read More »Glycemic Variability (GV) Increases Risk For Poorer Outcomes
Maintaining a steady GV through lifestyle, proper treatment regimen, and responsible dietary nutrition can help manage a type 2 diabetic condition.
Read More »Medication Adherence and its Effect on Diabetes Outcomes
Is there a benefit to keeping it “simple” when determining appropriate regimens for patients with diabetes?
Read More »Liraglutide Use in Youth with Type 2 Diabetes
Results from a phase 3 trial investigating the use of liraglutide in children and adolescents.
Read More »